Achromobacter xylosoxidans

Last updated

Achromobacter xylosoxidans
Achromobacter xylosoxidans.tif
Scientific classification
Domain:
Phylum:
Class:
Order:
Family:
Genus:
Species:
A. xylosoxidans
Binomial name
Achromobacter xylosoxidans
Yabuuchi and Yano 1981 [1]
Type strain
ATCC 27061, BCRC 12839, CCM 2741, CCRC 12839, CCTM La 3521, CCUG 12689, CDC KC 1064, CDCKC1064, CECT 467 = Colección Española de Cultivos, CECT 927, CGMCC 1.2007, CIP 71.32, DSM 10346, DSM 2402, DSMZ 10346, DSMZ 2402, EY 543, GIFL 543, GIFU 543, Hugh 2838, IAM 12684, IFO 15126, IMD 101001, JCM 9659, KACC 10205, KM 543, LMG 1863, NBRC 15126, NCIB 12033, NCIMB 12033, NCTC 1 O807, NCTC 10807, NRRL 84082, NRRL B-4082, NXRX 10807, PCM 2222, R-16924, R. Hugh 2838, R.Hugh 2838, RH 2838, RIMD 101001, strain KM 543, strain Takeda, VTT E-991282 Yabuuchi KM 543 [2]

Achromobacter xylosoxidans (formerly Alcaligenes xylosoxidans) is a Gram-negative, aerobic, oxidase and catalase-positive, motile bacterium with peritrichous flagella, from the genus Achromobacter . It is generally found in wet environments. Achromobacter xylosoxidans can cause infections such as bacteremia, [3] [4] especially in patients with cystic fibrosis. [5] In 2013, the complete genome of an A. xylosoxidans strain from a patient with cystic fibrosis was sequenced. [6]

Contents

Bacteriology

A. xylosoxidans is a Gram-negative rod that does not form spores. It is motile, with peritrichous flagella that distinguish it from Pseudomonas species, and is oxidase-positive, catalase-positive, and citrate-positive. It is urease and indole-negative. It produces acid oxidatively from xylose, but not from lactose, maltose, mannitol, or sucrose. It grows well on MacConkey agar and other inhibitory growth media such as deoxycholate, Salmonella-Shigella, and nalidixic acid-cetrimide agars. [3] [7] [8]

It is usually resistant to a variety of antibiotics including penicillins, cephalosporins, quinolones, and aminoglycosides. Ampicillin and carbenicillin, which are penicillins, are an exception. It is variably susceptible to tetracyclines, chloramphenicol, trimethoprim-sulfamethoxazole, and colistin. [7]

Pathogenesis and clinical characteristics

Originally isolated from patients with otitis media, [7] A. xylosoxidans has since been periodically described as a pathogen of humans. In addition to otitis, it can cause a variety of other infections, including pneumonia, pharyngitis, peritonitis in association with catheters used for peritoneal dialysis, and urinary tract infections. [3] [9] Infection is sometimes associated with underlying immunodeficiency, including immunoglobulin M deficiency, various cancer chemotherapies, inhaled steroids, surgical procedures, prolonged or broad-spectrum antimicrobial treatment for other infections, [3] and cystic fibrosis. [5] It has also been the cause of hospital-acquired infections. [9]

See also

Related Research Articles

<i>Proteus mirabilis</i> Species of bacterium

Proteus mirabilis is a Gram-negative, facultatively anaerobic, rod-shaped bacterium. It shows swarming motility and urease activity. P. mirabilis causes 90% of all Proteus infections in humans. It is widely distributed in soil and water. Proteus mirabilis can migrate across the surface of solid media or devices using a type of cooperative group motility called swarming. Proteus mirabilis is most frequently associated with infections of the urinary tract, especially in complicated or catheter-associated urinary tract infections.

<i>Pseudomonas aeruginosa</i> Species of bacterium

Pseudomonas aeruginosa is a common encapsulated, gram-negative, aerobic–facultatively anaerobic, rod-shaped bacterium that can cause disease in plants and animals, including humans. A species of considerable medical importance, P. aeruginosa is a multidrug resistant pathogen recognized for its ubiquity, its intrinsically advanced antibiotic resistance mechanisms, and its association with serious illnesses – hospital-acquired infections such as ventilator-associated pneumonia and various sepsis syndromes.

<i>Moraxella catarrhalis</i> Species of bacterium

Moraxella catarrhalis is a fastidious, nonmotile, Gram-negative, aerobic, oxidase-positive diplococcus that can cause infections of the respiratory system, middle ear, eye, central nervous system, and joints of humans. It causes the infection of the host cell by sticking to the host cell using trimeric autotransporter adhesins.

<i>Stenotrophomonas maltophilia</i> Species of bacterium

Stenotrophomonas maltophilia is an aerobic, nonfermentative, Gram-negative bacterium. It is an uncommon bacterium and human infection is difficult to treat. Initially classified as Bacterium bookeri, then renamed Pseudomonas maltophilia, S. maltophilia was also grouped in the genus Xanthomonas before eventually becoming the type species of the genus Stenotrophomonas in 1993.

<i>Alcaligenes</i> Genus of bacteria

Alcaligenes is a genus of Gram-negative, aerobic, rod-shaped bacteria in the order of Burkholderiales.

<i>Chromobacterium violaceum</i> Species of bacterium

Chromobacterium violaceum is a Gram-negative, facultative anaerobic, non-sporing coccobacillus. It is motile with the help of a single flagellum which is located at the pole of the coccobacillus. Usually, there are one or two more lateral flagella as well. It is part of the normal flora of water and soil of tropical and sub-tropical regions of the world. It produces a natural antibiotic called violacein, which may be useful for the treatment of colon and other cancers. It grows readily on nutrient agar, producing distinctive smooth low convex colonies with a dark violet metallic sheen. Some strains of the bacteria which do not produce this pigment have also been reported. It has the ability to break down tarballs.

<i>Elizabethkingia meningoseptica</i> Species of bacterium

Elizabethkingia meningoseptica is a Gram-negative, rod-shaped bacterium widely distributed in nature. It may be normally present in fish and frogs; it may be isolated from chronic infectious states, as in the sputum of cystic fibrosis patients. In 1959, American bacteriologist Elizabeth O. King was studying unclassified bacteria associated with pediatric meningitis at the Centers for Disease Control and Prevention in Atlanta, when she isolated an organism that she named Flavobacterium meningosepticum. In 1994, it was reclassified in the genus Chryseobacterium and renamed Chryseobacterium meningosepticum(chryseos = "golden" in Greek, so Chryseobacterium means a golden/yellow rod similar to Flavobacterium). In 2005, a 16S rRNA phylogenetic tree of Chryseobacteria showed that C. meningosepticum along with C. miricola were close to each other but outside the tree of the rest of the Chryseobacteria and were then placed in a new genus Elizabethkingia named after the original discoverer of F. meningosepticum.

<i>Mycobacteroides abscessus</i> Species of bacterium

Mycobacteroides abscessus is a species of rapidly growing, multidrug-resistant, nontuberculous mycobacteria that is a common soil and water contaminant. Although M. abscessus most commonly causes chronic lung infection and skin and soft tissue infection (SSTI), it can also cause infection in almost all human organs, mostly in patients with suppressed immune systems. Amongst NTM species responsible for disease, infection caused by M. abscessus complex are more difficult to treat due to antimicrobial drug resistance.

<i>Enterobacter cloacae</i> Species of bacterium

Enterobacter cloacae is a clinically significant Gram-negative, facultatively-anaerobic, rod-shaped bacterium.

<i>Morganella morganii</i> Species of bacterium

Morganella morganii is a species of Gram-negative bacteria. It has a commensal relationship within the intestinal tracts of humans, mammals, and reptiles as normal flora. Although M. morganii has a wide distribution, it is considered an uncommon cause of community-acquired infection, and it is most often encountered in postoperative and other nosocomial infections, such as urinary tract infections.

Pasteurella canis is a Gram-negative, nonmotile, penicillin-sensitive coccobacillus of the family Pasteurellaceae. Bacteria from this family cause zoonotic infections in humans, which manifest themselves as skin or soft-tissue infections after an animal bite. It has been known to cause serious disease in immunocompromised patients.

Lautropia mirabilis is a Gram-negative, facultatively anaerobic, oxidase- and catalase-positive, motile bacterium of the genus Lautropia and family Burkholderiaceae, isolated from the mouth of children who were infected with human immunodeficiency virus.

Pandoraea apista is a Gram-negative, catalase-positive, aerobic, non-spore-forming, motile bacterium with a single polar flagellum, of the genus Pandoraea. The Strain CCUG 38412 was isolated from the sputum of a cystic fibrosis patient in Denmark. Pandoraea apista can cause lung disease, such as chronic lung infections, in patients who suffer from cystic fibrosis.

Achromobacter denitrificans is a Gram-negative, oxidase- and catalase-positive, strictly aerobic, ubiquitous, motile bacterium with peritrichous flagella from the genus Achromobacter which was isolated from soil and can cause human infections.

Bordetella trematum is a species of Gram-negative bacteria identified in 1996 by comparison of 10 strains of B. trematum against other well characterized Bordetella and Alcaligenes species. The term trema refers to something pierced or penetrated, or to a gap. "Trematum" pertains to open things, and refers to the presence of bacteria in wounds and other exposed parts of the body. Strain LMG 13506T is the reference strain for this species.

Brucella anthropi is a bacterium. The type strain is strain CIP 82.115. O. anthropi strains are rod-shaped, aerobic, gram-negative, non-pigmented and motile by means of peritrichous flagella. They are emerging as major opportunistic pathogens.

Anaerococcus is a genus of bacteria. Its type species is Anaerococcus prevotii. These bacteria are Gram-positive and strictly anaerobic. The genus Anaerococcus was proposed in 2001. Its genome was sequenced in August 2009. The genus Anaerococcus is one of six genera classified within the group GPAC. These six genera are found in the human body as part of the commensal human microbiota.

Bilophila wadsworthia is a Gram-negative, obligately anaerobic, catalase-positive, bile-resistant, and asaccharolytic bacillus. Approximately 75% of B. wadsworthia strains are urease positive. B. wadsworthia is linked to various diseases and is not well known due to frequent misidentification of the bacteria, and the National Center for Biotechnology Information is including it the phylum of Proteobacteria. The two unique characteristics of B. wadsworthia are the utilisation of the sulfated amino acid taurine in the production of hydrogen sulfide and the rapid catalase reaction. This bacterium is susceptible to the β-lactam antibiotics imipenem, cefoxitin, and ticarcillin.

Christensenella hongkongensis is a species of clinically relevant gram-positive coccobacilli, first isolated from patients in Hong Kong and Canada in 2006. Although the species remains relatively rare, it has a high mortality rate of up to 50%. Christensenella is thought to be broadly distributed globally, as it has been isolated from patient blood cultures around the world including Hong Kong, South Korea, New Zealand, Canada, Sweden, France and Italy. Fewer than 15 cases of C. hongkongensis have been observed worldwide.

Neisseria animaloris, formerly named CDC group EF-4a, is a gram-negative coccoid rod. The bacterium is a commensal of the upper respiratory tract of cats and dogs, and they may cause pulmonary infections in cat. In humans Neisseria animaloris have been reported to cause wound infection after animal bites but also chronic otitis media, bacteremia and endophtalmitis.

References

  1. "Genus Achromobacter". LPSN (List of Prokaryotic Names with Standing in Nomenclature). Retrieved 11 November 2015.
  2. "Taxon Passport: Achromobacter xylosoxidans". StrainInfo. Archived from the original on 4 March 2018. Retrieved 11 November 2015.
  3. 1 2 3 4 Igra-Siegman, Y.; Chmel, H.; Cobbs, C. (February 1980). "Clinical and Laboratory Characteristics of Achromobacter xylosoxidans Infection". Journal of Clinical Microbiology. 11 (2): 141–145. doi:10.1128/jcm.11.2.141-145.1980. PMC   273340 . PMID   7358838.
  4. Duggan, J.M.; Goldstein, S.J.; Chenoweth, C.E.; Kauffman, C.A.; Bradley, S.F. (1996). "Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature". Clinical Infectious Diseases. 23 (3): 569–576. doi:10.1093/clinids/23.3.569. PMID   8879782.
  5. 1 2 "Achromobacter xylosoxidans". Cystic Fibrosis Medicine. Retrieved 11 November 2015.
  6. Jakobsen, T.H.; Hansen, M.A.; Jensen, P.Ø.; Hansen, L.; Riber, L.; et al. (22 July 2013). "Complete Genome Sequence of the Cystic Fibrosis Pathogen Achromobacter xylosoxidans NH44784-1996 Complies with Important Pathogenic Phenotypes". PLOS ONE. 8 (7): e68484. doi: 10.1371/journal.pone.0068484 . PMC   3718787 . PMID   23894309.
  7. 1 2 3 Yabuuchi, Eiko; Ohyama, Akio (1971). "Achromobacter xylosoxidans n. sp. from Human Ear Discharge". Japanese Journal of Microbiology. 15 (5): 477–481. doi: 10.1111/j.1348-0421.1971.tb00607.x . PMID   5316576.
  8. Holmes, B.; Snell, J.J.S.; Lapage, S.P. (1977). "Strains of Achromobacter xylosoxidans From Clinical Material". Journal of Clinical Pathology. 30 (7): 595–601. doi:10.1136/jcp.30.7.595. PMC   476493 . PMID   886012.
  9. 1 2 Gomez-Cerezo, J.; Suarez, I.; Rios, J.J.; Pena, P.; Garcia de Miguel, M.J.; et al. (16 May 2003). "Achromobacter xylosoxidans Bacteremia: A 10-Year Analysis of 54 Cases". European Journal of Clinical Microbiology and Infectious Diseases. 22 (6): 360–363. doi:10.1007/s10096-003-0925-3. PMID   12750959. S2CID   2017576.